2020 ASCO Virtual Direct™ Highlights


 

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclitaxel + Ramucirumab, T-DXd in HER2+Disease

394 views
September 16, 2020
1 Comment
Login to view comments. Click here to Login